These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31061955)

  • 1. Interleukin-33/ST2-Mediated Inflammation Plays a Critical Role in the Pathogenesis and Severity of Type I Autoimmune Hepatitis.
    Abe K; Takahashi A; Fujita M; Hayashi M; Okai K; Nozawa Y; Ohira H
    Hepatol Commun; 2019 May; 3(5):670-684. PubMed ID: 31061955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-21 plays a critical role in the pathogenesis and severity of type I autoimmune hepatitis.
    Abe K; Takahashi A; Imaizumi H; Hayashi M; Okai K; Kanno Y; Watanabe H; Ohira H
    Springerplus; 2016; 5(1):777. PubMed ID: 27386263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum 25-hydroxyvitamin D levels with severe necroinflammatory activity and inflammatory cytokine production in type I autoimmune hepatitis.
    Abe K; Fujita M; Hayashi M; Takahashi A; Ohira H
    PLoS One; 2020; 15(11):e0239481. PubMed ID: 33151930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Levels of IL-33 and Correlation with IL-4, IL-17A, and Hypergammaglobulinemia in Patients with Autoimmune Hepatitis.
    Liang M; Liwen Z; Yun Z; Yanbo D; Jianping C
    Mediators Inflamm; 2018; 2018():7964654. PubMed ID: 30034292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis.
    Migita K; Nakamura M; Aiba Y; Kozuru H; Abiru S; Komori A; Fujita Y; Temmoku J; Asano T; Sato S; Furuya M; Naganuma A; Yoshizawa K; Shimada M; Ario K; Mannami T; Kohno H; Kaneyoshi T; Komura T; Ohira H; Yatsuhashi H
    PLoS One; 2020; 15(12):e0238540. PubMed ID: 33347507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis.
    Biewenga M; Heidt S; Vergunst M; Marijnissen CMJ; de Man RA; van der Eijk AA; van der Meer AJ; Trouw LA; van Hoek B
    JHEP Rep; 2022 May; 4(5):100460. PubMed ID: 35368991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum soluble ST2 is a promising prognostic biomarker in HBV-related acute-on-chronic liver failure.
    Jiang SW; Wang P; Xiang XG; Mo RD; Lin LY; Bao SS; Lu J; Xie Q
    Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):181-188. PubMed ID: 28381383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating complement factor H levels are associated with disease severity and relapse in autoimmune hepatitis.
    Hayashi M; Abe K; Fujita M; Takahashi A; Sekine H; Ohira H
    JHEP Rep; 2022 Jul; 4(7):100497. PubMed ID: 35677590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased serum DNase1-activity in patients with autoimmune liver diseases.
    Gatselis NK; Vakrakou AG; Zachou K; Androutsakos T; Azariadis K; Hatzis G; Manoussakis MN; Dalekos GN
    Autoimmunity; 2017 Mar; 50(2):125-132. PubMed ID: 28263100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble ST2 plasma concentrations predict mortality in HBV-related acute-on-chronic liver failure.
    Lei Z; Mo Z; Zhu J; Pang X; Zheng X; Wu Z; Wang K; Li X; Xie D; Gao Z
    Mediators Inflamm; 2015; 2015():535938. PubMed ID: 25892854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis.
    Saeki C; Matsuzaki J; Kuroda M; Fujita K; Ichikawa M; Takizawa S; Takano K; Oikawa T; Nakanuma Y; Saruta M; Ochiya T; Tsubota A
    BMJ Open Gastroenterol; 2022 Apr; 9(1):. PubMed ID: 35379653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of serum sST2 is associated with poor prognosis in acute-on-chronic hepatitis B liver failure.
    Gao S; Huan SL; Han LY; Li F; Ji XF; Li XY; Fan YC; Wang K
    Clin Res Hepatol Gastroenterol; 2015 Jun; 39(3):315-23. PubMed ID: 25481239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and pathological characteristics and outcome of 46 children with autoimmune hepatitis].
    Cao LL; Zhang M; Zhu SS; Dong Y; Xu ZQ; Chen DW; Wang LM; Wang FC; Gan Y; Yan JG; Wang P; Li AQ
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):40-45. PubMed ID: 30630230
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical features of 107 autoimmune hepatitis patients and 30 of them with AIH-primary biliary cirrhosis overlap syndrome].
    Qiu DK; Li XM; Wei J; Ye LJ; Peng YS; Ma X
    Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):367-71. PubMed ID: 18510851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune hepatitis type 1 and primary biliary cirrhosis have distinct bone marrow cytokine production.
    Zachou K; Rigopoulou EI; Tsikrikoni A; Alexandrakis MG; Passam F; Kyriakou DS; Stathakis NE; Dalekos GN
    J Autoimmun; 2005 Dec; 25(4):283-8. PubMed ID: 16242912
    [TBL] [Abstract][Full Text] [Related]  

  • 16.  Elevated circulating levels of IL-21 and IL-22 define a cytokine signature profile in type 2 autoimmune hepatitis patients.
    Thomas-Dupont P; Remes-Troche JM; Izaguirre-Hernández IY; Sánchez-Vargas LA; Maldonado-Rentería Mde J; Hernández-Flores KG; Torre A; Bravo-Sarmiento E; Vivanco-Cid H
    Ann Hepatol; 2016; 15(4):550-8. PubMed ID: 27236154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Leptin Serves as an Inflammatory Activity Marker and Predicts Steroid Response in Autoimmune Hepatitis.
    Lal D; Thakur M; Bihari C
    J Clin Exp Hepatol; 2020; 10(6):574-580. PubMed ID: 33311894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-33 promotes disease progression in patients with primary biliary cirrhosis.
    Sun Y; Zhang JY; Lv S; Wang H; Gong M; Du N; Liu H; Zhang N; Jing J; Zhou C; Zhang F; Wang Z
    Tohoku J Exp Med; 2014 Dec; 234(4):255-61. PubMed ID: 25400121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Type 2 Innate Lymphoid Cells in Patients with Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome.
    Tsai YG; Liou JH; Hung SI; Chen CB; Chiu TM; Wang CW; Chung WH
    J Invest Dermatol; 2019 Aug; 139(8):1722-1731. PubMed ID: 30735685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-33 and Soluble ST2 Levels in Infants with Hypoxic-Ischemic Encephalopathy.
    Hamano H; Takahashi K; Kimura S; Matsuguma C; Kaneyasu H; Fujimoto Y; Ohta N; Okada S; Hasegawa S
    Neonatology; 2023; 120(3):353-362. PubMed ID: 36996771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.